Featured Search - Analysis Shows USPSTF Evidence Backs Mammography at 40
Radiologists from the University of Colorado and the University of Michigan contend that evidence actually shows the benefits of mammography screening women aged 40 to 49 greatly outweigh the possible risks.
Top news from a Feb. 1 featured radiology search on SearchMedica: preventive imaging
United States Preventive Services Task Force Screening Mammography Recommendations: Science IgnoredAmerican Journal of Roentgenology | Feb 1, 2011 (Free abstract. Full text: $10)
Taking a close look at the evidence on which the USPSTF recommended against mammography screening for women aged 40 to 49, radiologists from the University of Colorado and the University of Michigan contend that it actually shows the benefits greatly outweigh the possible risks.
Related Content from Diagnostic Imaging:
The USPSTF Breast Cancer Screening Guidelines: Current and Future Implications
Several months have passed since the publication of the latest US Preventive Services Task Force (USPSTF) breast cancer screening guidelines. The initial, sharp outcry, mainly over the task force’s recommendation against routine screening mammography for women aged 40 to 49 years, has somewhat subsided, but the overall significance of the group’s decision remains undetermined.
Experts Outraged as FDA Panel Says Screening Mammography Should Begin at 50
The U.S. Preventive Services Task Force has issued a recommendation against routine breast cancer screening for women ages 40 to 49 and suggests the screening interval should be changed from every year to every two years beginning at age 50. The new recommendations will result in "many needless deaths," said a joint statement from the American College of Radiology and the Society of Breast Imaging.
Preview: Mammography Rallies on Political Leap Forward
The technological and political evolution of digital mammography will be in evidence on the RSNA exhibit floor.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
